| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
Department of Pathology [M-J. K., B-J. P., D-S. B., J-I. P., J-H. P., S-G. C.] and Division of Gastroenterology [H-J. K.], Department of Internal Medicine, School of Medicine, Kyung Hee University, 130-701 Seoul, Republic of Korea
The p73 gene located at 1p36.3 encodes for a protein with significant similarity to p53. To investigate the penetrance of p73 in gastric carcinogenesis, we analyzed the expression, allelotype, and mutation of p73 in five cell lines and 75 tissues. Although extremely low levels of p73 expression were observed in all noncancerous gastric tissues and four of five cell lines, a significant elevation of p73 was detected in 37 of 39 (94.9%) carcinoma tissues. Furthermore, a tumor-specific increase of p73 was identified in 14 of 16 (87.5%) matched sets. Allelotyping analysis using a StyI or BanI polymorphism revealed that 5 of 21 (23.8%) informative carcinomas, but none of 19 noncancerous cases, express p73 biallelically, suggesting the transcriptional activation of a silent allele in a subset of cancers. Whereas the transcription of an active allele was markedly induced by serum starvation or clump formation of the cells, treatment with 5-aza-2'deoxycytidine activated a silent allele with a subsequent up-regulation of an active allele, supporting the genomic imprinting and autoregulation of the gene. Allelic deletion or mutation of the gene was not found, and no association of p73 expression with the mutational status of p53 or expression of p21Waf1 was recognized. Taken together, this study argues that p73 is not a target of genetic alteration in gastric carcinogenesis and suggests that overexpression of p73 might be triggered by physiological stresses accompanied with outgrowth of tumors, such as hypoxia or nutrient deprivation.
This article has been cited by other articles:
|
|
 |
|
  U. Nyman, A. Sobczak-Pluta, P. Vlachos, T. Perlmann, B. Zhivotovsky, and B. Joseph Full-length p73{alpha} Represses Drug-induced Apoptosis in Small Cell Lung Carcinoma Cells J. Biol. Chem., October 7, 2005; 280(40): 34159 - 34169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Pfeifer, G. Arbman, and X.-F. Sun Polymorphism of the p73 gene in relation to colorectal cancer risk and survival Carcinogenesis, January 1, 2005; 26(1): 103 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Li, L.-E Wang, R. M. Chamberlain, C. I. Amos, M. R. Spitz, and Q. Wei p73 G4C14-to-A4T14 Polymorphism and Risk of Lung Cancer Cancer Res., October 1, 2004; 64(19): 6863 - 6866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Li, E. M. Sturgis, L.-E. Wang, R. M. Chamberlain, C. I. Amos, M. R. Spitz, A. K. El-Naggar, W. K. Hong, and Q. Wei Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck Carcinogenesis, October 1, 2004; 25(10): 1911 - 1916. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. M. Moll and N. Slade p63 and p73: Roles in Development and Tumor Formation Mol. Cancer Res., July 1, 2004; 2(7): 371 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Das, W. S. El-Deiry, and K. Somasundaram Regulation of the p53 Homolog p73 by Adenoviral Oncogene E1A J. Biol. Chem., May 9, 2003; 278(20): 18313 - 18320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Guan, H.-X. Peng, B. Yu, and Y. Lu p73 Overexpression and Angiogenesis in Human Colorectal Carcinoma Jpn. J. Clin. Oncol., May 1, 2003; 33(5): 215 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Pilozzi, C Talerico, A Platt, C Fidler, and L Ruco p73 gene mutations in gastric adenocarcinomas Mol. Pathol., February 1, 2003; 56(1): 60 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-S. Byun, M.-G. Lee, K.-S. Chae, B.-G. Ryu, and S.-G. Chi Frequent Epigenetic Inactivation of RASSF1A by Aberrant Promoter Hypermethylation in Human Gastric Adenocarcinoma Cancer Res., October 1, 2001; 61(19): 7034 - 7038. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Irwin and W. G. Kaelin p53 Family Update: p73 and p63 Develop Their Own Identities Cell Growth Differ., July 1, 2001; 12(7): 337 - 349. [Full Text] [PDF]
|
|
|
|
|
|
A. Zaika, M. Irwin, C. Sansome, and U. M. Moll Oncogenes Induce and Activate Endogenous p73 Protein J. Biol. Chem., March 30, 2001; 276(14): 11310 - 11316. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
